Stichting Viecuri Medisch Centrum voor Noord-Limburg — Clinical Trial Site

61 Registered trials

28 Currently recruiting

Organisation

Stichting Viecuri Medisch Centrum voor Noord-Limburg

Location

Venlo, Netherlands

Identifier

ORG-100042907

Address

Tegelseweg 210, 5912 BL, Netherlands

Departments

#2904:Cardiology
#3711: Cardiology
2621:Cardiology
3711: Cardiology
Cardiologie
Cardiology
chirurgie
Department of Oncology
Dermatology
Emergency Department
Endocrinologie
General Medicine
Hematology
Intensive care
Internal medicine - oncology
Internal medicine / Oncology
Internal Medicine Oncology
Internal Medicine/oncology
internal oncology
Interne geneeskunde
Interne geneeskunde oncologie
Medical Oncology
Medische Oncologie
Nefrologie
Neurologie
Neurology
Oncologiecentrum routenummer 71
Oncology
Poli Cardiologie route 61
Pulmonary Science
Pulmonology
Rheumatology
Rheumatology Department
VieCuri

Clinical trials at this site (61)

Search interface

CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended

2022-502324-48-00 Patients with resected colon carcinoma 5 2014-08-05
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin… Ended

2024-516202-39-00 Metastatic breast cancer 4 2013-10-10
A study in subjects with gout flares that investigates the effect, safety, tolerability, and pharmacokinetics (absorption, distribution, met… Ended

2023-508793-29-00 Gout flares 3 2025-01-07
GENPAD Ended

2024-518122-33-00 Peripheral Arterial Disease 6 2024-12-13
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 Acute Coronary Syndrome 5 2023-11-21
A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events ( KRAKEN ) Ended

2022-501466-21-00 Lipoprotein Disorder 4 2023-03-01
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Prevention of stroke or systemic embolism in atrial fib 5 2022-11-24
A Phase 3, randomized, double-blind, placebo-controlled, multicenter study of IV FDY-5301 in patients with a myocardial infarction (STEMI) Ended

2024-514372-40-00 Anterior ST-Elevation Myocardial Infarction 5 2022-04-12
Investigation to assess the effects of zalunfiban in patients with an acute heart attack Ended

2023-508485-15-00 Subjects with documented STEMI, presenting with persist 5 2021-04-22
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 Adults at high risk of cardiovascular events without pr 5 2019-05-24
TOFA-PREDICT Ended

2024-510903-12-00 Psoriatic arthritis 6
REDUAL PCI Real Life Registry Ended

2024-518666-27-00 Acute coronary syndrome 11